Director and executive Hu Wei of Pulike Biological Engineering, Inc. (603566.SH) completes the reduction of 800,000 shares.

12/02/2025

GMT Eight

Pulike Biological Engineering,Inc.(603566.SH) announced that as of February 12, 2025, the company's director and senior management personnel, Hu Wei, has reduced his holding of company shares by 800,000 shares through bulk trading, accounting for 0.2312% of the total share capital of the company. The reduction plan has been completed.

Zhejiang Wansheng (603010.SH) intends to invest in the construction of a subsidiary company in Zhuhai to produce 25,000 tons of impact-resistant modified agents annually.

SWIREPROPERTIES (01972) spent 9.1365 million Hong Kong dollars to repurchase 600,000 shares on February 12th.

Contact: contact@gmteight.com

Director and executive Hu Wei of Pulike Biological Engineering, Inc. (603566.SH) completes the reduction of 800,000 shares.

RECOMMEND

GDS-SW(09698): DayOne does not have specific or final plans for an initial public offering.

QYUNS-B (02509) received the notification of acceptance of the application and supplemental application for marketing approval for ustekinumab in the treatment of Crohn's disease.

Shenzhen Urban Transport Planning Center (301091.SZ): Zhuhai Dao Yuan Holdings falls to below 5%